InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

80
Insider
Date
Role
Action
Shares
Price
Amount
Ronald Peck
11 Aug 2023
Chief Medical Officer
Sold after exercise
1,324
$24.39
$32.29K
Sean A Cassidy
1 Mar 2023
Chief Financial Officer
Sold after exercise
1,745
$29.53
$51.53K
John G Houston
1 Mar 2023
President and CEO
Sold after exercise
5,878
$29.53
$173.58K
Ian Taylor
1 Mar 2023
Chief Scientific Officer
Sold after exercise
1,051
$29.53
$31.04K
Ronald Peck
12 Aug 2022
Chief Medical Officer
Sold after exercise
1,258
$68.99
$86.79K
Briggs Morrison
14 Apr 2022
Director
Sold after exercise
10,754
$67.03
$720.89K
Briggs Morrison
14 Apr 2022
Director
Sold after exercise
7,104
$66.07
$469.36K
Briggs Morrison
14 Apr 2022
Director
Sold after exercise
3,102
$65.24
$202.37K
Sean A Cassidy
11 Mar 2022
Chief Financial Officer
Sold after exercise
15,000
$70.00
$1.05M
John G Houston
4 Mar 2022
President and CEO
Sold after exercise
6,024
$63.94
$385.17K
Sean A Cassidy
4 Mar 2022
Chief Financial Officer
Sold after exercise
1,593
$63.94
$101.86K
Ian Taylor
4 Mar 2022
Chief Scientific Officer
Sold after exercise
869
$63.94
$55.56K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
100
$76.58
$7.66K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
300
$75.80
$22.74K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
3,841
$74.64
$286.69K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
4,126
$73.68
$304.00K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
5,766
$72.55
$418.32K
Ian Taylor
15 Feb 2022
Chief Scientific Officer
Sold after exercise
5,867
$71.74
$420.90K
Briggs Morrison
14 Jan 2022
Director
Sold after exercise
2,108
$67.69
$142.70K
Briggs Morrison
14 Jan 2022
Director
Sold after exercise
5,100
$67.28
$343.14K
Briggs Morrison
14 Jan 2022
Director
Sold after exercise
3,833
$65.24
$250.07K
Briggs Morrison
14 Jan 2022
Director
Sold after exercise
9,919
$64.33
$638.11K
Ronald Peck
30 Dec 2021
Chief Medical Officer
Sold after exercise
8,629
$80.96
$698.60K
Ronald Peck
30 Dec 2021
Chief Medical Officer
Sold after exercise
11,371
$80.35
$913.66K
Sean A Cassidy
17 Dec 2021
Chief Financial Officer
Sold after exercise
15,000
$70.00
$1.05M
Ian Taylor
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,484
$84.95
$550.84K
Ian Taylor
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,660
$84.14
$560.39K
Ian Taylor
15 Nov 2021
Chief Scientific Officer
Sold after exercise
6,856
$83.07
$569.51K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise indirect
2,747
$89.86
$246.85K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise indirect
8,676
$91.09
$790.30K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise indirect
15,327
$91.81
$1.41M
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise indirect
1,825
$93.03
$169.79K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise indirect
4,519
$94.08
$425.14K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
484
$89.65
$43.39K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
795
$90.29
$71.78K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
5,221
$91.59
$478.19K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
4,940
$90.75
$448.31K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
7,060
$91.50
$645.99K
Liam Ratcliffe
5 Nov 2021
Director
Sold after exercise
6,423
$91.50
$587.70K
John G Houston
1 Nov 2021
President and CEO
Sold after exercise
15,569
$88.86
$1.38M
John G Houston
1 Nov 2021
President and CEO
Sold after exercise
15,918
$87.98
$1.40M
John G Houston
1 Nov 2021
President and CEO
Sold after exercise
8,513
$87.13
$741.75K
Ian Taylor
16 Aug 2021
Chief Scientific Officer
Sold after exercise
301
$88.28
$26.57K
Ian Taylor
16 Aug 2021
Chief Scientific Officer
Sold after exercise
10,462
$87.67
$917.20K
Ian Taylor
16 Aug 2021
Chief Scientific Officer
Sold after exercise
9,237
$86.84
$802.14K
Ronald Peck
12 Aug 2021
Chief Medical Officer
Sold after exercise
1,363
$90.54
$123.40K
John G Houston
2 Aug 2021
President and CEO
Sold after exercise
2,746
$100.66
$276.41K
John G Houston
2 Aug 2021
President and CEO
Sold after exercise
3,441
$99.96
$343.96K
John G Houston
2 Aug 2021
President and CEO
Sold after exercise
7,600
$98.86
$751.34K
John G Houston
2 Aug 2021
President and CEO
Sold after exercise
6,992
$97.66
$682.84K
John G Houston
2 Aug 2021
President and CEO
Sold after exercise
25,143
$96.96
$2.44M
Sean A Cassidy
28 Jul 2021
Chief Financial Officer
Sold after exercise
17,242
$100.00
$1.72M
Ronald Peck
30 Jun 2021
Chief Medical Officer
Sold after exercise
20,000
$76.69
$1.53M
John G Houston
10 Jun 2021
President and CEO
Sold after exercise
14,487
$82.46
$1.19M
John G Houston
10 Jun 2021
President and CEO
Sold after exercise
11,784
$81.75
$963.37K
John G Houston
10 Jun 2021
President and CEO
Sold after exercise
17,615
$80.52
$1.42M
John G Houston
9 Jun 2021
President and CEO
Sold after exercise
700
$80.15
$56.10K
Ian Taylor
5 Apr 2021
Chief Scientific Officer
Sold after exercise
4,450
$67.56
$300.64K
Ian Taylor
5 Apr 2021
Chief Scientific Officer
Sold after exercise
16,450
$66.80
$1.10M
Ian Taylor
5 Apr 2021
Chief Scientific Officer
Sold after exercise
4,100
$66.01
$270.64K
John G Houston
2 Mar 2021
President and CEO
Sold after exercise
8,115
$77.45
$628.50K
Sean A Cassidy
2 Mar 2021
Chief Financial Officer
Sold after exercise
2,221
$77.45
$172.02K
Ian Taylor
2 Mar 2021
Chief Scientific Officer
Sold after exercise
894
$77.45
$69.24K
Ronald Peck
16 Feb 2021
Chief Medical Officer
Sold after exercise
20,000
$77.35
$1.55M
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
30
$80.43
$2.41K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
1,161
$79.42
$92.21K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
6,160
$78.65
$484.46K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
2,793
$77.62
$216.79K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
396
$80.28
$31.79K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
3,958
$79.32
$313.93K
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
19,303
$78.61
$1.52M
Sean A Cassidy
16 Feb 2021
Chief Financial Officer
Sold after exercise
8,158
$77.60
$633.04K
John G Houston
16 Feb 2021
President and CEO
Sold after exercise
600
$80.25
$48.15K
John G Houston
16 Feb 2021
President and CEO
Sold after exercise
13,223
$79.72
$1.05M
John G Houston
16 Feb 2021
President and CEO
Sold after exercise
21,249
$78.66
$1.67M
John G Houston
16 Feb 2021
President and CEO
Sold after exercise
8,928
$77.62
$692.98K
Ronald Peck
14 Aug 2020
Chief Medical Officer
Sold after exercise
1,256
$27.46
$34.49K
Sean A Cassidy
19 Mar 2020
Chief Financial Officer
Sold after exercise
1,514
$37.61
$56.94K
Ian Taylor
19 Mar 2020
Chief Scientific Officer
Sold after exercise
826
$37.61
$31.07K
John G Houston
19 Mar 2020
President and CEO
Sold after exercise
5,405
$37.61
$203.28K
Show all 240 transactions →

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 80
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 25,802,990
Sales filed before the plan box existed 81
History held since 28 Sep 2018